HighTower Advisors’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $339K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $421K | Buy |
|
|||||
|
2024
Q1 | $424K | Buy |
|
|||||
|
2023
Q4 | $296K | Buy |
|
|||||
|
2023
Q3 | $242K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $2.6M | Buy |
|
|||||
|
2021
Q4 | $203K | Sell |
|
|||||
|
2021
Q3 | $200K | Buy |
|
|||||
|
2021
Q2 | $203K | Buy |
|
|||||
|
2021
Q1 | $238K | Hold |
|
|||||
|
2020
Q4 | $200K | Sell |
|
|||||
|
2020
Q3 | $260K | Buy |
|
|||||
|
2020
Q2 | $205K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $237K | Sell |
|
|||||
|
2018
Q3 | $274K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $275K | Hold |
|
|||||
|
2017
Q3 | $226K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $219K | Sell |
|
|||||
|
2015
Q4 | $325K | Buy |
|